Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

Published:2023-01 Issue:1 Volume:35 Page:84-100.e8
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Yang Fan,Xiao Yi,Ding Jia-Han,Jin Xi,Ma Ding,Li Da-Qiang,Shi Jin-Xiu,Huang Wei,Wang Yi-Ping,Jiang Yi-Zhou,Shao Zhi-Ming

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference71 articles.

1. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade;Ayers;J. Clin. Invest.,2017

2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis;Bersuker;Nature,2019

3. Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism;Bertolio;Nat. Commun.,2019

4. 2,4-Dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer;Blomme;Nat. Commun.,2020

5. Prominin2 drives ferroptosis resistance by stimulating iron export;Brown;Dev. Cell,2019

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S. glabra exerts anti-lung cancer effects by inducing ferroptosis and anticancer immunity;Phytomedicine;2024-11

2. STIM1 promotes acquired resistance to sorafenib by attenuating ferroptosis in hepatocellular carcinoma;Genes & Diseases;2024-11

3. Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials;Journal of Drug Delivery Science and Technology;2024-10

4. Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy;CHINESE CHEM LETT;2024

5. Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy;Chinese Chemical Letters;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3